Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 441-450 of 10261

Edit search filters
  1. A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System

    Scottsdale/Phoenix, AZ

  2. SC16LD6.5 in Recurrent Small Cell Lung Cancer

    Rochester, MN

  3. A Study to Assess the BioTraceIO System for Identifying Tissue Damage from Microwave Thermal Liver Ablation

    Scottsdale/Phoenix, AZ

  4. Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian)

  5. Submandibular Gland Needle Core Biopsy and Skin Punch Biopsy as Tissue Biomarkers for the Diagnosis and Monitoring of Disease Progression of Parkinson’s Disease and REM Sleep Behavior Disorder

    Scottsdale/Phoenix, AZ

  6. A Study to Understand the Physical Characteristics of Healthy and Diseased Artery Walls

    Rochester, MN

  7. Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

    Rochester, MN

  9. A Study of Entresto in Tetralogy of Fallot (TOF) and Ebstein’s Anomaly (EA)

    Rochester, MN

  10. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation

    Rochester, MN

.

Mayo Clinic Footer